Publications

Yadong Huang, MD, PhDBrodbeck J, Balestra ME, Saunders AM, Roses AD, Mahley RW, Huang Y. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc Natl Acad Sci U S A. 2008 Jan 29; 105(4):1343-6. View in: PubMed
Yadong Huang, MD, PhDApolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. View in: PubMed
Yadong Huang, MD, PhDMahley RW, Huang Y, Weisgraber KH. Detrimental effects of apolipoprotein E4: potential therapeutic targets in Alzheimer's disease. Curr Alzheimer Res. 2007 Dec; 4(5):537-40. View in: PubMed
Yadong Huang, MD, PhDApolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. View in: PubMed
Yadong Huang, MD, PhDMahley RW, Huang Y. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. J Clin Invest. 2007 Jan; 117(1):94-8. View in: PubMed
Yadong Huang, MD, PhDIntron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS. View in: PubMed
Yadong Huang, MD, PhDHuang Y. Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies. Curr Opin Drug Discov Devel. 2006 Sep; 9(5):627-41. View in: PubMed
Yadong Huang, MD, PhDRosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. View in: PubMed
Yadong Huang, MD, PhDRoses AD, Saunders AM, Huang Y, Strum J, Weisgraber KH, Mahley RW. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenomics J. 2007 Feb; 7(1):10-28. View in: PubMed
Yadong Huang, MD, PhDDetrimental effects of apolipoprotein E4: potential therapeutic targets in Alzheimer's disease. View in: PubMed